Coney Island Hospital
Brooklyn, New York, United States
Teaching hospital in Brooklyn, New York
2601 Ocean Pkwy, Brooklyn, NY 11235
371 Beds
About Coney Island Hospital
Coney Island Hospital is a public teaching hospital located in the Coney Island neighborhood of Brooklyn, New York City. It is owned by NYC Health + Hospitals, a public benefit corporation of the city.
There are 371 beds in Coney Island Hospital.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
6
Coney Island Hospital, Brooklyn, NY
2
NYU Langone Health
2
Abbott Medical Devices
1
Boehringer Ingelheim
1
Canadian Cancer Trials Group
1
Clinical Directors Network
1
Memorial Sloan Kettering Cancer Center
1
NSABP Foundation Inc
1
New York City Health and Hospitals Corporation
1
SWOG Cancer Research Network
1
Clinical Trials at Coney Island Hospital
During the past decade, Coney Island Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 12 clinical trials were completed, i.e. on
average, 171.4% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
2006-04-07
2030-09-30
Active, not recruiting
10,273
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
2006-08-01
2023-12-01
Active, not recruiting
3,966
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
2007-11-02
Active, not recruiting
4,994
Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
2008-10-13
2017-06-15
Completed
799
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
2009-05-15
Active, not recruiting
454
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
2009-07-15
2022-02-08
Completed
1,333
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
2010-06-25
2022-07-31
Completed
3,649
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Coney Island Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 6 trials, followed by "Coney Island Hospital, Brooklyn, NY" with 2 trials
sponsored, "NYU Langone Health" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "Boehringer Ingelheim"
with 1 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Coney Island Hospital"
#1 collaborator was "Cancer and Leukemia Group B" with 3 trials as a collaborator, "National Cancer Institute (NCI)" with 3 trials as a collaborator, "North Central Cancer Treatment Group" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator. Other collaborators include 24 different institutions and companies that were
collaborators in the rest 33 trials.
Clinical Trials Conditions at Coney Island Hospital
According to Clinical.Site data, the most researched conditions in "Coney Island Hospital" are
"Breast Cancer" (3 trials), "Stage IIA Breast Cancer AJCC v6 and v7" (3 trials), "Stage IIB Breast Cancer AJCC v6 and v7" (3 trials), "Breast Adenocarcinoma" (2 trials) and "Coronary Artery Disease" (2 trials). Many other conditions were trialed in "Coney Island Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Coney Island Hospital
Most popular intervention types in "Coney Island Hospital" are "Drug" (15 trials), "Other" (12 trials), "Biological" (6 trials), "Behavioral" (4 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (7 trials), "Bevacizumab" (5 trials), "Paclitaxel" (5 trials), "Cyclophosphamide" (3 trials) and "Doxorubicin Hydrochloride" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Coney Island Hospital
The vast majority of trials in "Coney Island Hospital" are
16 trials for "All" genders and 4 trials for "Female" genders.
Clinical Trials Status at Coney Island Hospital
Currently, there are NaN active trials in "Coney Island Hospital".
undefined are not yet recruiting,
undefined are recruiting,
8 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Coney Island Hospital,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Coney Island Hospital, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 2 trials that are defined as “Not Applicable".